个人中心
登出
中文简体
返回
-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
登录后咨询在线客服
回到顶部
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
周三盘中有12只医疗保健类股走势
Gainers
- Statera BioPharma (NASDAQ:STAB) shares increased by 16.92% to $3.16 during Wednesday's regular session. The market value of their outstanding shares is at $87.2 million.
- Tarsus Pharmaceuticals (NASDAQ:TARS) stock rose 15.62% to $31.0. Trading volume for this security as of 12:30 EST is 54.5K, which is 192.49% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $637.7 million.
- NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares moved upwards by 15.21% to $2.12. As of 12:30 EST, NeuroBo Pharmaceuticals's stock is trading at a volume of 12.5 million, which is 533.84% of its average full-day volume over the last 100 days. The company's market cap stands at $56.3 million.
- Relay Therapeutics (NASDAQ:RLAY) stock moved upwards by 14.58% to $31.82. Relay Therapeutics's stock is trading at a volume of 3.2 million shares as of 12:30 EST. This is 490.61% of its average full-day volume over the last 100 days. The company's market cap stands at $2.9 billion.
- Sesen Bio (NASDAQ:SESN) shares increased by 13.59% to $0.94. Trading volume for this security as of 12:30 EST is 6.0 million, which is 30.69% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $184.2 million.
- Aditxt (NASDAQ:ADTX) stock increased by 13.32% to $2.05. The current volume of 3.9 million shares is 72.42% of Aditxt's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $43.2 million.
Losers
- Regulus Therapeutics (NASDAQ:RGLS) shares decreased by 30.36% to $0.53 during Wednesday's regular session. As of 12:30 EST, Regulus Therapeutics's stock is trading at a volume of 13.5 million, which is 1454.87% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $46.0 million.
- NeuroOne Medical Tech (NASDAQ:NMTC) shares decreased by 28.18% to $2.96. NeuroOne Medical Tech's stock is trading at a volume of 1.1 million shares as of 12:30 EST. This is 394.37% of its average full-day volume over the last 100 days. The company's market cap stands at $35.5 million.
- Ardelyx (NASDAQ:ARDX) shares decreased by 19.53% to $1.06. Trading volume for this security as of 12:30 EST is 12.4 million, which is 120.12% of its average full-day volume over the last 100 days. The company's market cap stands at $109.5 million.
- Rezolute (NASDAQ:RZLT) stock declined by 17.09% to $6.31. The current volume of 770.9K shares is 5478.92% of Rezolute's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $54.3 million.
- Neuronetics (NASDAQ:STIM) shares declined by 15.63% to $5.4. The current volume of 1.5 million shares is 356.45% of Neuronetics's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $142.1 million.
- NRX Pharmaceuticals (NASDAQ:NRXP) shares declined by 13.19% to $9.48. As of 12:30 EST, this security is trading at a volume of 3.8 million shares, making up 72.25% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $509.7 million.
See Also: www.benzinga.com/money/best-healthcare-stocks/
Gainers
赢家
- Statera BioPharma (NASDAQ:STAB) shares increased by 16.92% to $3.16 during Wednesday's regular session. The market value of their outstanding shares is at $87.2 million.
- Tarsus Pharmaceuticals (NASDAQ:TARS) stock rose 15.62% to $31.0. Trading volume for this security as of 12:30 EST is 54.5K, which is 192.49% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $637.7 million.
- NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares moved upwards by 15.21% to $2.12. As of 12:30 EST, NeuroBo Pharmaceuticals's stock is trading at a volume of 12.5 million, which is 533.84% of its average full-day volume over the last 100 days. The company's market cap stands at $56.3 million.
- Relay Therapeutics (NASDAQ:RLAY) stock moved upwards by 14.58% to $31.82. Relay Therapeutics's stock is trading at a volume of 3.2 million shares as of 12:30 EST. This is 490.61% of its average full-day volume over the last 100 days. The company's market cap stands at $2.9 billion.
- Sesen Bio (NASDAQ:SESN) shares increased by 13.59% to $0.94. Trading volume for this security as of 12:30 EST is 6.0 million, which is 30.69% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $184.2 million.
- Aditxt (NASDAQ:ADTX) stock increased by 13.32% to $2.05. The current volume of 3.9 million shares is 72.42% of Aditxt's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $43.2 million.
- Statera BioPharma纳斯达克股票代码:STAB)股价在周三的例会中上涨16.92%,至3.16美元。他们流通股的市值为8720万美元。
- 塔尔苏斯制药公司纳斯达克股票代码:TARS)股价上涨15.62%,至31.0美元。截至美国东部时间12:30,这只证券的成交量为54.5K,是过去100日全天平均成交量的192.49%。他们流通股的市值为6.377亿美元。
- NeuroBo制药公司纳斯达克市场代码:NRBO)股价上涨15.21%,至2.12美元。截至美国东部时间12:30,NeuroBo PharmPharmticals的股票成交量为1,250万股,是其过去100日全天平均成交量的533.84。该公司的市值为5630万美元。
- 接力疗法纳斯达克股票代码:RLAY)股价上涨14.58%,至31.82美元。截至美国东部时间12:30,Relay Treeutics的股票交易量为320万股。这是过去100日平均全天交易量的490.61%。该公司的市值为29亿美元。
- SESEN Bio纳斯达克市场代码:SESN)股价上涨13.59%,至0.94美元。截至美国东部时间12:30,该证券成交量为600万口,是过去100天全天平均成交量的30.69%。他们流通股的市值为1.842亿美元。
- Aditxt(纳斯达克市场代码:ADTX)股票上涨13.32%,至2.05美元。目前390万股的成交量是Aditxt过去100天全天平均成交量的72.42%(最近一次更新是在美国东部时间12:30)。他们流通股的市值为4320万美元。
Losers
失败者
- Regulus Therapeutics (NASDAQ:RGLS) shares decreased by 30.36% to $0.53 during Wednesday's regular session. As of 12:30 EST, Regulus Therapeutics's stock is trading at a volume of 13.5 million, which is 1454.87% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $46.0 million.
- NeuroOne Medical Tech (NASDAQ:NMTC) shares decreased by 28.18% to $2.96. NeuroOne Medical Tech's stock is trading at a volume of 1.1 million shares as of 12:30 EST. This is 394.37% of its average full-day volume over the last 100 days. The company's market cap stands at $35.5 million.
- Ardelyx (NASDAQ:ARDX) shares decreased by 19.53% to $1.06. Trading volume for this security as of 12:30 EST is 12.4 million, which is 120.12% of its average full-day volume over the last 100 days. The company's market cap stands at $109.5 million.
- Rezolute (NASDAQ:RZLT) stock declined by 17.09% to $6.31. The current volume of 770.9K shares is 5478.92% of Rezolute's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $54.3 million.
- Neuronetics (NASDAQ:STIM) shares declined by 15.63% to $5.4. The current volume of 1.5 million shares is 356.45% of Neuronetics's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $142.1 million.
-
NRX Pharmaceuticals (NASDAQ:NRXP) shares declined by 13.19% to $9.48. As of 12:30 EST, this security is trading at a volume of 3.8 million shares, making up 72.25% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $509.7 million.
See Also: www.benzinga.com/money/best-healthcare-stocks/
- Regulus治疗公司纳斯达克市场代码:RGLS)股价在周三的例会中下跌30.36%,至0.53美元。截至美国东部时间12:30,Regulus Treeutics的股票成交量为1,350万股,是其过去100日全天平均成交量的1454.87%。他们流通股的市值为4600万美元。
- NeuroOne医疗技术公司纳斯达克市场代码:NMTC)股价下跌28.18%,至2.96美元。截至美国东部时间12:30,NeuroOne Medical Tech的股票交易量为110万股。这是过去100日平均全天交易量的394.37%。该公司的市值为3550万美元。
- 阿德莱克斯纳斯达克市场代码:ARDX)股价下跌19.53%,至1.06美元。截至美国东部时间12:30,该证券的成交量为1,240万口,是过去100日全天平均成交量的120.12。该公司的市值为1.095亿美元。
- Rezolute纳斯达克市场代码:RZLT)股价下跌17.09%,至6.31美元。目前770.9K股的成交量是Rezolute过去100日全天平均成交量的5478.92(最近一次更新是在美国东部时间12:30)。该公司的市值为5430万美元。
- 神经病学(纳斯达克市场代码:STIM)股价下跌15.63%,至5.4美元。目前150万股的成交量是Neuronetics过去100日全天平均成交量的356.45%(最近一次更新是在美国东部时间12:30)。该公司市值为1.421亿美元。
-
NRX制药公司纳斯达克市场代码:NRXP)股价下跌13.19%,至9.48美元。截至美国东部时间12:30,这只证券的成交量为380万股,占其过去100天的全天平均成交量的72.25%。他们流通股的市值为5.097亿美元。
另见:Www.benzinga.com/money/best-healthcare-stocks/
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
点击这里分享给好友
暂无评论,快来抢沙发吧!